A message from PacTec, Inc.

Innovating for the Nuclear Industry

Astatine-211 targets blood-borne cancers in Seattle clinical trials

September 13, 2022, 9:30AMNuclear News

A clinical dose of At-211 is prepared at the University of Washington for use in a Fred Hutchison Cancer Center clinical trial. (Photo: UW/Don Hamlin)

Scientists in the Departments of Radiation Oncology and Medicine at the University of Washington (UW) and Fred Hutchinson Cancer Center (Fred Hutch) are directly targeting cancerous cells traveling through patients’ bloodstreams with diseases such as leukemia and lymphoma using an intravenous injection of the radioactive isotope astatine-211 (At-211). The work, its challenges, and its promise were described in a recent news release from the National Isotope Development Center (NIDC), which is managed by the Department of Energy’s Isotope Program.

To continue reading, log in or create a free account!

NNSA to use essential—but unpaid—workers to keep weapons stockpile safe if shutdown continues

October 10, 2025, 3:18PMNuclear News

On day 10 of the government shutdown, the National Nuclear Security Administration has yet to furlough workers, but a spokesperson said that could change if members of Congress don’t agree...

Holtec pulls out of New Mexico SNF interim storage project

October 10, 2025, 7:01AMRadwaste Solutions

Holtec International has confirmed it is canceling plans to build a consolidated interim storage facility for spent nuclear fuel in southeastern New Mexico. Named the HI-STORE CISF, the...

NRC nominee Nieh commits to independent safety mission

October 8, 2025, 3:00PMNuclear News

During a Senate Environment and Public Works Committee hearing today, Ho Nieh, President Donald Trump’s nominee to serve as a commissioner at the Nuclear Regulatory Commission, was urged to...

DOE, NNSA open process to select energy suppliers for AI data centers

October 8, 2025, 12:03PMNuclear News

The Department of Energy’s Office of Environmental Management and Office of Science and the National Nuclear Security Administration issued requests for proposals last month, seeking plans...

DOE, NRC prepare for government shutdown

October 1, 2025, 12:03PMNuclear News

The Department of Energy and the Nuclear Regulatory Commission will furlough thousands of employees and operate at reduced capacity under a government shutdown that started after midnight on...

Four companies picked for fast-tracked fuel fabrication

October 1, 2025, 9:30AMNuclear News

The Department of Energy has fast-tracked its selections for the Fuel Line Pilot Program. Four companies—Oklo, Terrestrial Energy, TRISO-X, and Valar Atomics—were named September 30 as...

Oklo breaks ground at INL on Aurora reactor

September 29, 2025, 6:25AMNuclear News

Following the same milestones from Aalo Atomics and Valar Atomics, Santa Clara, Calif.–based reactor start-up Oklo has become the third company participating in the Department of Energy’s...

Deep Isolation licenses its disposal technology to fed contractor Navarro

September 26, 2025, 9:30AMRadwaste Solutions

Nuclear waste disposal technology company Deep Isolation Nuclear announced it has signed a technology licensing agreement with government contractor Navarro Research and Engineering, giving...

Centrus says Ohio stands to gain 300 jobs as enrichers await federal contracts

September 26, 2025, 7:01AMNuclear News

Centrus Energy announced a plan yesterday to add 300 new jobs at Centrus’s uranium enrichment plant in Piketon, Ohio, “in advance of federal funding decisions.” The company envisions...

Orano to supply Zeno with Am-241 to power space missions

September 24, 2025, 3:00PMNuclear News

Zeno Power, a developer of nuclear batteries, is to receive americium-241 recovered from Orano’s La Hague nuclear fuel recycling site in Normandy, France, under a strategic agreement...

Astatine-211 targets blood-borne cancers in Seattle clinical trials

Related Articles